Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Primary objective of the study is to investigate the safety and efficacy of a titration phase (8 hours) and a maintenance phase (maximum 40 hours) of intravenous BAY 58-2667 in patients with acute decompensated chronic congestive heart failure with the need for parenteral pharmacotherapy and invasive haemodynamic monitoring (i.e. indwelling Swan-Ganz pulmonary artery catheter) and PCWP ≥ 18mmHg.
Critère d'inclusion
- Patients with acute decompensated chronic congested heart failure